Skip to main content

Table 1 Brazilian cohort – clinical characteristics of participants by CAD status

From: Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects

  With CAD Without CAD p
Subjects (n) 406 188  
Sex: Male (%) 63 50 0.0005
Age (y) 60 ± 11 57 ± 11 0.0001
Diabetes mellitus (%) 48 52 0.35
Fasting plasma glucose (mmol/l) 7 ± 2.78 6.39 ± 1.89 0.03
HbA1c (%) 6.8 ± 1.6 6.6 ± 1.5 0.11
BMI (kg/m2) 27.1 ± 4.6 28.0 ± 5.0 0.06
Dyslipidemia (%) 95 86 0.01
Triglycerides (mmol/l)* 1.47[1.00-1.95] 1.36[0.89-1.84] 0.0002
LDL Cholesterol (mmol/l) 2.59 ± 0.93 2.67 ± 0.88 0.40
HDL Cholesterol (mmol/l) 0.98 ± 0.28 1.09 ± 0.28 0.0001
eGFR(ml/min) 84 ± 24 89 ± 28 0.05
Hypertension (%) 91 90 0.51
Systolic BP (mmHg) 140 ± 24 136 ± 20 0.09
Diastolic BP (mmHg) 80 ± 14 79 ± 13 0.54
Tobacco smoking (%) 57 42 0.003
  1. Data expressed in mean ± SD, except *expressed in median [interquartile range]. CAD coronary artery disease, HbA1c glycated hemoglobin, eGFR estimated glomerular filtration rate. Differences between groups were assessed by Pearson’s chi squared test and ANOVA.